Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020–2022)
Hélio S. Sader, Cecília G Carvalhaes, John H. Kimbrough, Rodrigo E. Mendes, Mariana Castanheira
Topics & Concepts
Ceftazidime/avibactamAztreonamAvibactamBroth microdilutionMeropenemImipenemMicrobiologyMedicineCarbapenemBiologyCeftazidimeAntibioticsAntibiotic resistanceBacteriaMinimum inhibitory concentrationGeneticsPseudomonas aeruginosaAntibiotic Resistance in BacteriaInfections and bacterial resistanceNosocomial Infections in ICU